analyst
SN
NASDAQ · SNDX
Syndax Pharmaceuticals, Inc.
Healthcare · Biotechnology
$19.54
Down-$0.62 (-3.08%)
Updated Aug 31, 2026, 3:03 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.77B
- P/E ratio
- -5.67
- Dividend yield
- 0.00%
- 52-week range
- $16.66 – $25.59
- Volume
- 1.04M
- Avg. volume
- 2.74M
Price performance
SNDX price history
1M range · 20 trading sessions · Daily adjusted prices
SNDX closed at $19.54 after 20 trading sessions, up 1.56% for the selected period.
- Last close
- $19.54
- Period change
- +1.56%
- Period low
- $19.08
- Period high
- $20.77
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $19.98 | $20.045 | $19.47 | $19.54 | 1.04M |
| Aug 27, 2026 | $20.01 | $20.23 | $19.70 | $20.16 | 652.36K |
| Aug 26, 2026 | $19.92 | $20.22 | $19.60 | $20.09 | 789.97K |
| Aug 25, 2026 | $19.73 | $20.40 | $19.70 | $19.92 | 975K |
| Aug 24, 2026 | $19.70 | $19.87 | $19.17 | $19.57 | 1.44M |
| Aug 21, 2026 | $19.93 | $20.28 | $19.25 | $19.65 | 1.7M |
| Aug 20, 2026 | $20.39 | $20.72 | $19.64 | $19.75 | 1.12M |
| Aug 19, 2026 | $20.67 | $20.875 | $20.01 | $20.77 | 1.19M |
| Aug 18, 2026 | $19.83 | $20.10 | $19.67 | $19.915 | 1.02M |
| Aug 17, 2026 | $19.52 | $20.275 | $19.285 | $19.76 | 1.1M |
| Aug 14, 2026 | $19.08 | $19.86 | $18.82 | $19.84 | 1.25M |
| Aug 13, 2026 | $19.89 | $20.02 | $19.04 | $19.08 | 1.2M |
| Aug 12, 2026 | $20.26 | $20.7117 | $19.685 | $19.80 | 1.07M |
| Aug 11, 2026 | $20.46 | $20.575 | $19.93 | $20.29 | 790.97K |
| Aug 10, 2026 | $20.40 | $20.65 | $20.07 | $20.37 | 1.02M |
| Aug 7, 2026 | $19.96 | $20.41 | $19.72 | $20.40 | 1.25M |
| Aug 6, 2026 | $19.61 | $20.39 | $19.38 | $19.76 | 1.48M |
| Aug 5, 2026 | $17.31 | $20.31 | $17.20 | $19.92 | 3.78M |
| Aug 4, 2026 | $19.56 | $19.85 | $19.00 | $19.08 | 2.04M |
| Aug 3, 2026 | $19.01 | $19.41 | $18.675 | $19.24 | 1.61M |
Latest SNDX news
The latest Smart Investors Daily articles mentioning SNDX.
Stock researchResearch & News · SEC Filings
Loading stock research…